{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Barrett's esophagus",
      "epigenetic changes",
      "esophageal cancer",
      "molecular pathways",
      "oncotransformation",
      "preventative targets"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34870375",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/cam4.4447"
    ],
    "Journal": {
      "ISSN": "2045-7634",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "2",
        "PubDate": {
          "Year": "2022",
          "Month": "Jan"
        }
      },
      "Title": "Cancer medicine",
      "ISOAbbreviation": "Cancer Med"
    },
    "ArticleTitle": "Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.",
    "Pagination": {
      "StartPage": "447",
      "EndPage": "478",
      "MedlinePgn": "447-478"
    },
    "Abstract": {
      "AbstractText": [
        "Barrett's esophagus is a widespread chronically progressing disease of heterogeneous nature. A life threatening complication of this condition is neoplastic transformation, which is often overlooked due to lack of standardized approaches in diagnosis, preventative measures and treatment. In this essay, we aim to stratify existing data to show specific associations between neoplastic transformation and the underlying processes which predate cancerous transition. We discuss pathomorphological, genetic, epigenetic, molecular and immunohistochemical methods related to neoplasia detection on the basis of Barrett's esophagus. Our review sheds light on pathways of such neoplastic progression in the distal esophagus, providing valuable insight into progression assessment, preventative targets and treatment modalities. Our results suggest that molecular, genetic and epigenetic alterations in the esophagus arise earlier than cancerous transformation, meaning the discussed targets can help form preventative strategies in at-risk patient groups."
      ],
      "CopyrightInformation": "\u00a9 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-8083-9428"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Institute of Human Morphology, Moscow, Russian Federation."
          }
        ],
        "LastName": "Maslyonkina",
        "ForeName": "Ksenia S",
        "Initials": "KS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Institute of Human Morphology, Moscow, Russian Federation."
          }
        ],
        "LastName": "Konyukova",
        "ForeName": "Alexandra K",
        "Initials": "AK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Institute of Human Morphology, Moscow, Russian Federation."
          }
        ],
        "LastName": "Alexeeva",
        "ForeName": "Darya Y",
        "Initials": "DY"
      },
      {
        "Identifier": [
          "0000-0002-0862-6011"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Institute of Human Morphology, Moscow, Russian Federation."
          }
        ],
        "LastName": "Sinelnikov",
        "ForeName": "Mikhail Y",
        "Initials": "MY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Institute of Human Morphology, Moscow, Russian Federation."
          }
        ],
        "LastName": "Mikhaleva",
        "ForeName": "Liudmila M",
        "Initials": "LM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Med",
    "NlmUniqueID": "101595310",
    "ISSNLinking": "2045-7634"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Barrett Esophagus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epigenesis, Genetic"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Esophageal Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Precancerous Conditions"
    }
  ],
  "CoiStatement": "The authors declare no conflicts of interest in the writing and preparation of this article."
}